Melbourne, Aug 25, 2009 (ABN Newswire) - Mesoblast Limited (ASX:MSB)(PINK:MBLTY) today announced that its United States-based associate company Angioblast Systems Inc. has closed a A$10 million equity-based financing from institutional and sophisticated investors. New investors oversubscribed the financing, with A$3 million coming from existing Angioblast shareholders.
